BC055111 Inhibitors
BC055111 Inhibitors belong to a class of chemical compounds that have garnered significant attention in the field of molecular biology and biochemistry. These inhibitors are specifically designed to target and modulate the activity of BC055111, which is a protein-coding gene often associated with various cellular processes. BC055111 itself is a member of the long non-coding RNA (lncRNA) family, and its function in cellular regulation and gene expression modulation is not yet fully understood. Consequently, researchers have turned to BC055111 Inhibitors as valuable tools to investigate the roles of this gene in various biological contexts.
BC055111 Inhibitors can vary widely, but their primary function is to bind to BC055111 and alter its activity. This binding can result in the suppression or enhancement of specific cellular processes, depending on the inhibitor's mode of action. Researchers utilize these inhibitors in laboratory settings to decipher the functional significance of BC055111 in processes such as gene regulation, cell signaling, and molecular pathways. The development and utilization of BC055111 Inhibitors contribute to a deeper understanding of the intricate mechanisms governing cellular behavior and gene expression.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $68.00 $312.00 | 2 | |
Alsterpaullone is an inhibitor that targets several kinases, including cyclin-dependent kinases (CDKs), which could indirectly affect Cdc42-interacting protein 4 (CIMAP2) by altering the cell cycle and cytoskeletal dynamics. | ||||||
Gö 6976 | 136194-77-9 | sc-221684 | 500 µg | $227.00 | 8 | |
Go6976 is a protein kinase C (PKC) inhibitor that may influence cellular processes related to CIMAP2 activity by altering signal transduction pathways that intersect with PKC. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a ROCK inhibitor that can impact CIMAP2 by affecting cellular shape, motility, and possibly the regulatory pathways involving the actin cytoskeleton. | ||||||
ZCL278 | 587841-73-4 | sc-507369 | 10 mg | $115.00 | ||
ZCL278 is a Cdc42 inhibitor, which can influence CIMAP2-associated pathways by modulating the actin cytoskeleton and related signaling pathways. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
ML141 is another Cdc42 inhibitor that can modify the cytoskeletal organization and signal transduction pathways, potentially impacting CIMAP2 function. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an MEK inhibitor that can alter the ERK/MAPK signaling pathway, which intersects with various cellular pathways, potentially affecting CIMAP2-associated processes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can affect numerous signaling cascades, including those related to cell survival and motility, which may intersect with CIMAP2's role. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which can disrupt signaling pathways and cellular processes that are potentially linked with CIMAP2 activity. | ||||||
(±)-Blebbistatin | 674289-55-5 | sc-203532B sc-203532 sc-203532A sc-203532C sc-203532D | 5 mg 10 mg 25 mg 50 mg 100 mg | $183.00 $313.00 $464.00 $942.00 $1723.00 | 7 | |
Blebbistatin is a myosin II inhibitor that can impact muscle contraction and cell motility, potentially affecting pathways where CIMAP2 is involved. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
CK-666 is an Arp2/3 complex inhibitor that can disrupt actin polymerization, which may in turn influence CIMAP2-related cellular activities. | ||||||